# Eli Lilly and Company (LLY) — Q1-2016 Earnings Results

**Report date:** 2016-04-26 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2016

## Post-Earnings Brief

### Headline

Eli Lilly Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.83 | N/A | -3.38% |

### Management Commentary

**Tone:** Defensive

Management expressed caution regarding current market conditions. They are committed to navigating challenges while focusing on future growth.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized a focus on long-term growth despite short-term hurdles.

### Guidance Changes

No guidance data is available for this quarter.

### What It Means

This earnings report indicates that Eli Lilly faced some challenges, as evidenced by the EPS miss. The lack of revenue data and guidance updates leaves investors with limited insight into future performance. The stock reaction is not available, which may reflect uncertainty in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2016_